A Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing Cells
- 21 July 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (17), 4163-4165
- https://doi.org/10.1021/jm034182u
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- QSAR: Hydropathic analysis of inhibitors of the p53–mdm2 interactionProteins: Structure, Function, and Bioinformatics, 2001
- Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53Biochemistry, 2000
- The α-helical FXXΦΦ motif in p53: TAF interaction and discrimination by MDM2Proceedings of the National Academy of Sciences of the United States of America, 1999
- The MDM2 gene amplification databaseNucleic Acids Research, 1998
- Molecular characterization of the hdm2-p53 interactionJournal of Molecular Biology, 1997
- Amplification and Overexpression of MDM2 in Primary (de novo) GlioblastomasJournal of Neuropathology and Experimental Neurology, 1997
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996
- A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.Genes & Development, 1996
- Low grade amplification of MDM2 gene in a subset of human breast cancers without p53 alterationsBreast Cancer, 1994
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993